Login
$BAX
$25.54 +$0.00 (0.0%) After hours

$BAX SEC Filings

Filed On Filing
29 Oct 2026 10-Q
29 Oct 2026 8-K: Results of Operations and Financial Condition; Other Events

DEERFIELD, Ill., OCT. 29, 2026 – Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2026.

27 Oct 2026 SCHEDULE 13G/A
02 Oct 2026 Form 3: Rogers Terence John, EVP and CFO

Holds 0 shares of Common Stock, $1 par value

18 Sep 2026 Form 3: Heine Bernard, AVP, Finance InterimCAO&Cntrlr

Holds 32,840 shares of Common Stock, $1 par value

03 Sep 2026 Form 4: Teaff James, President, CCS

Gave up 750 shares to cover exercise price or tax ($19.1K)

03 Sep 2026 Form 4: Hider Andrew P., Director

Gave up 54,276 shares to cover exercise price or tax ($1.39M)

03 Sep 2026 Form 4: Foster Julie, President, Front Line Care

Gave up 2,098 shares to cover exercise price or tax ($53.9K)

19 Aug 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

We are pleased to welcome you to Baxter International Inc. (“Baxter” or the “Company”) and to confirm our verbal offer of employment, subject to formal approval by the Board of Directors of Baxter (the “Board”). This is where your purpos...

18 Aug 2026 8-K: Entry into a Material Definitive Agreement; Other Events

AMENDMENT NO. 2, dated as of August 18, 2026 (this “Amendment”), among Baxter International Inc., a Delaware corporation (the “Borrower Representative”), Baxter Healthcare SA (the “Swiss Borrower” and, together with Borrower Representati...

04 Aug 2026 8-K: Departure/Election of Directors or Officers; Compensation

On July 31, 2026, Anita Zielinski notified Baxter International Inc. (the “Company”) of her decision to resign as the Company’s Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller, effective...

04 Aug 2026 8-K: Other Events

DEERFIELD, Ill., Aug. 4, 2026 - Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced that it has commenced cash tender offers (each, an “Offer” and collectively, the “Offers”) for the maximum principal amount ...

30 Jul 2026 10-Q
30 Jul 2026 8-K: Results of Operations and Financial Condition; Other Events

DEERFIELD, Ill., JULY 30, 2026 – Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2026.

14 Jul 2026 8-K: Regulation FD Disclosure

The following tables present our U.S. and international disaggregated net sales.

05 Jun 2026 SCHEDULE 13G/A
03 Jun 2026 Form 4: Zielinski Anita A, SVP, Interim CFO, CAO & Cntrlr

Received 13,426 shares as a grant or award

03 Jun 2026 Form 4: Wallace Steven P., President, Adv. Surgery

Gave up 153 shares to cover exercise price or tax ($2.86K)

03 Jun 2026 Form 4: Teaff James, President, CCS

Gave up 321 shares to cover exercise price or tax ($6K)

29 May 2026 SD

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support